权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

An innate immune checkpoint in cancer immunotherapy

癌症免疫治疗中的先天免疫检查点

基本信息

批准号：
10286793
负责人：
Sourav Ghosh
金额：
$ 41.55万
依托单位：
YALE UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
2017
资助国家：
美国
起止时间：
2017-03-01 至 2023-02-28
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10286793
关键词：
Ablation Acceleration Adverse effects Age Age-Months Alzheimer&apos s Disease Alzheimer&apos s disease brain Alzheimer&apos s disease model Animals Anxiety Astrocytes Autoantigens Automobile Driving Behavioral Biological Assay Brain CTLA4 gene Cells Collaborations Complement Data Defect Dendritic Cells Development Disease Electron Microscopy Frequencies Future Gene Expression Profile Generations Genes Genetic Genetic Transcription Health Health protection Hippocampus (Brain)Histologic Homeostasis Immune Immune response Immunotherapeutic agent Immunotherapy Impaired cognition Impairment Individual Inflammation Institutes Israel Knock-out Knockout Mice Knowledge Laboratories Learning Light Lipofuscin MERTK gene Maintenance Malignant Neoplasms Memory Memory Loss Memory impairment Messenger RNA Microglia Modeling Moods Morphology Mus Natural Immunity Nerve Degeneration Neurocognitive Neurocognitive Deficit Parents Performance Phagocytes Phagocytosis Pharmacology Phenocopy Phenotype Phosphotransferases Photoreceptors Pilot Projects Proteins Receptor Protein-Tyrosine Kinases Resources Risk Role Structure of retinal pigment epithelium T cell response T-Lymphocyte TREM2 gene TYRO3 gene Testing Therapeutic Tissue-Specific Gene Expression Transcript Tumor-associated macrophages Work adaptive immune response adaptive immunity age related anti-tumor immune response axl receptor tyrosine kinase base behavior test brain health cancer immunotherapy clinical development conditional knockout experimental study immune checkpoint immune checkpoint blockade innate immune checkpoint loss of function macrophage mouse model neoplasm immunotherapy novel paralogous gene pathogen postnatal preclinical development programmed cell death protein 1 receptor function response scaffold tool tumor tumor-immune system interactions

项目摘要

Our application is a pilot project focused on eliminating unexpected adverse effects of cancer therapeutics by uncovering health risk of a new class of immunotherapeutics that are in clinical and preclinical development. Receptor tyrosine kinase (RTK) genes Tyro3, Axl and Mertk are paralogs that have been newly characterized as “innate immune checkpoints”. The blockade of this class of RTKs is in development as immunotherapies that can boost anti-tumor immune response. However, here we provide preliminary data that some paralogs are expressed in astrocytes and microglia in the brain, and are functionally important for the maintenance of brain health and neurocognitive functions. Specifically, loss of function of Mertk and Axl in astrocytes did not affect early postnatal brain development (P45), but astrocytes expressed unfolded protein response-genes in mice by 3-months of age, concomitant with these astrocytes undergoing spontaneous activation. By 9-months of age, we observed lipofuscin accumulation in the brain. Although performance in learning and memory tasks was normal at 3- and 6-months of age, 9-month old mice displayed defects in hippocampus-dependent learning and memory. Furthermore, we also observed that ablation of Axl in microglia in an Alzheimer's Disease (AD) mouse model (5xFAD mouse) accelerated learning and memory defects in these mice. In light of this novel knowledge of the functional requirement AXL and MERTK in the brain, we believe it is imperative to fully investigate if targeting the kinase activity of these RTKs can have adverse neurocognitive effects. Since kinases primarily function through their enzymatic activity to phosphorylate substrates, we are choosing to take this approach first. Therefore, our application also includes the development of a new resource – AXL kinase- dead or AxlKD mouse. A MertkKD is already available in our laboratory. We will use these mouse models to investigate the effect of targeting kinase function in brain homeostasis, and learning and memory. We will also investigate AXL function in the context of an AD mouse model. Notably, our approach is essentially identical with the approach used to generate the preliminary data. The same set of experiments included in the preliminary data will be performed on MertkKD and/or AxlKD mice. We will perform the assays at various ages to characterize the age-dependent onset of the phenotypes. Observed histological changes in the brain in the MertkKD and/or AxlKD mice, along with behavioral changes in the animal, will not only provide a novel understanding of MERTK and AXL kinase in the brain health and neurocognitive function, but will also provide a rationale for developing brain-excluded therapeutics for AXL- and/or MERTK-based tumor immunotherapy. Kinase-independent, scaffold-functions of kinases have also been described to exist. This will be pursued in the future if our studies fail to reveal the phenotype observed with genetic knockout of Axl or that of Axl and Mertk.

我们的应用是一个试点项目，重点是通过以下方式消除癌症治疗的意外不良影响揭示一类新的处于临床和临床前开发中的免疫疗法的健康风险。受体酪氨酸激酶(RTK)基因Tyro3、Ax1和MerTK是新发现的对偶基因被称为“先天免疫检查点”。对这类RTK的阻断正在作为免疫疗法开发中这可以增强抗肿瘤免疫反应。然而，我们在这里提供的初步数据表明，一些类似的在大脑中的星形胶质细胞和小胶质细胞中表达，并且在功能上对维持大脑健康和神经认知功能。具体地说，星形胶质细胞中MerTK和Axl功能的丧失没有影响出生后早期大脑发育(P45)，但星形胶质细胞表达未折叠蛋白反应基因 3个月大的小鼠，伴随着这些星形胶质细胞的自发激活。9个月前随着年龄的增长，我们观察到脂褐素在大脑中的积聚。尽管在学习和记忆任务中的表现在3个月和6个月龄时正常，9个月龄小鼠在依赖的海马区表现出缺陷学习和记忆。此外，我们还观察到，在阿尔茨海默病患者的小胶质细胞中，axl的消融疾病(AD)小鼠模型(5xFAD小鼠)加速了这些小鼠的学习和记忆缺陷。根据…… 这种新的知识对大脑中的AXL和MERTK的功能需求，我们认为这是势在必行的充分研究靶向这些RTK的激酶活性是否会对神经认知产生不利影响。自.以来激酶主要通过其对底物磷酸化的酶活性发挥作用，我们选择这是第一个方法。因此，我们的应用还包括开发一种新的资源-Axl激酶- 死亡或AxlKD小鼠。我们的实验室已经有了MertkKD。我们将使用这些鼠标模型来研究靶向激酶功能在脑内稳态和学习记忆中的作用。我们还将在AD小鼠模型的背景下研究Axl的功能。值得注意的是，我们的方法基本上是相同的用来生成初步数据的方法。同一组实验包括在初步数据将在MertkKD和/或AxlKD小鼠上进行。我们将在不同的年龄进行化验，以描述表型的年龄相关性发病特征。观察小鼠脑内组织学变化 MertkKD和/或AxlKD小鼠，连同动物的行为变化，不仅将提供一种新的了解MERTK和Axl激酶在大脑健康和神经认知功能中的作用，也将为为基于AXL和/或MERTK的肿瘤免疫治疗开发脑排除疗法的理论基础。激酶的非依赖性、支架功能也已被描述存在。这将在#年进行。如果我们的研究不能揭示通过基因敲除观察到的AXL或AXL和AXL的表型 MerTK。